Sign in
4

Changes in Ownership

Atea Pharmaceuticals, Inc. Filed Acc 0000950170-25-006489

Director bought 25,000 shares at an average $3.26 ($81,499)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BERGER FRANKLIN M Director 2025-01-15 Purchase −15,000 $3.19 $47,885 466,897 D
BERGER FRANKLIN M Director 2025-01-16 Purchase −10,000 $3.36 $33,614 476,897 D
Open-market purchases · 25,000 sh · avg $3.26 · $81,499
Loading xslF345X05/ownership.xml…